Page 1 of Clinical Trials for Drug Melphalan, 506 Total Matches
- 1RecruitingLast Updated: November 15, 2010Condition(s): Multiple Myeloma; Auto Stem Cell Transplant
- 2TerminatedLast Updated: March 30, 2009Condition(s): Multiple Myeloma
- 3Active, not recruitingLast Updated: September 6, 2011Condition(s): Drug/Agent Toxicity by Tissue/Organ; Mucositis; Multiple Myeloma and Plasma Cell Neoplasm
- 4Active, not recruitingLast Updated: May 9, 2009Condition(s): Drug/Agent Toxicity by Tissue/Organ; Multiple Myeloma and Plasma Cell Neoplasm
- 5RecruitingLast Updated: January 11, 2012Condition(s): Central Nervous System Embryonal Tumor; Germ Cell Tumors
- 6Active, not recruitingLast Updated: November 1, 2011Condition(s): Multiple Myeloma
- 7CompletedLast Updated: August 30, 2011Condition(s): Multiple Myeloma; Plasma Cell Neoplasm
- 8CompletedLast Updated: July 9, 2009Condition(s): Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma; Allogeneic Marrow Transplant
- 9CompletedLast Updated: December 27, 2010Condition(s): Neoplasms
- 10RecruitingLast Updated: January 31, 2012Condition(s): Multiple Myeloma
- 11RecruitingLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaLast Updated: March 15, 2011Condition(s): Multiple Myeloma
- 12RecruitingLast Updated: November 2, 2010Condition(s): Neuroblastoma
- 13Active, not recruitingLast Updated: August 31, 2009Condition(s): Multiple Sclerosis
- 14RecruitingLast Updated: June 2, 2011Condition(s): Metabolic Disorders; Hematologic, Immune, or Bone Marrow Disorders; Hemoglobinopathies
- 15Active, not recruitingLast Updated: February 6, 2009Condition(s): Leukemia
- 16TerminatedLast Updated: January 26, 2012Condition(s): Ovarian Cancer
- 17RecruitingLast Updated: November 22, 2011Condition(s): Melanoma
- 18RecruitingLast Updated: January 11, 2012Condition(s): Brain and Central Nervous System Tumors
- 19Active, not recruitingLast Updated: April 26, 2011Condition(s): Multiple Myeloma
- 20RecruitingLast Updated: January 9, 2012Condition(s): Amyloidosis
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Melphalan
